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Airﬂow obstructionAbstract Background and objective: The objective of our study was to test the hypothesis that
facial wrinkling is a reﬂection to the severity of COPD disease and whether there is an association
between facial wrinkling score and the severity of COPD as assessed by different parameters
retrieved from GOLD criteria as well as clinical based parameters. Therefore we aimed to investi-
gate whether extensive facial wrinkling should promote the screening of affected individuals for air-
ﬂow obstruction.
Subjects and methods: The study included 100 patients diagnosed with COPD. Demographic
data, smoking exposure as well as spirometric measures were obtained from all patients. Each
patient was given a score based on combined assessment of COPD system. The extent of facial wrin-
kling in the ‘‘crows’ feet area’’ was determined using the scoring system described by Daniell.
Results: The results of our study demonstrated that wrinkling score was statistically signiﬁcantly
higher in COPD patients with high risk based on combined assessment system compared to those
with low risk with p< 0.001. Also, a statistically signiﬁcantly higher score of wrinkling was found
in COPD patients with more symptoms based on mMRC breathlessness scale compared to those
with low symptoms with p< 0.001. We also found that wrinkling was statistically signiﬁcantly
higher in COPD patients with concomitant comorbidities compared to those without comorbidities
with p< 0.00. Positive correlations existed between wrinkling score and: age of the patients
(r= 0.738, p< 0.001), smoking severity of the patients (r= 0.326, p< 0.001), and severity of
COPD based on post bronchodilator FEV1 (r= 0.547, p< 0.001). There were also positive corre-
lations between wrinkling score and: risk of exacerbations (r= 0.333, p< 0.001), modiﬁed medical
research council breathlessness scale (r= 0.602, p< 0.001) and Combined COPD assessment
(r= 0.573, p< 0.001). There was a negative correlation between wrinkling score and post bron-
chodilator FEV1% of predicted values (r= 0.673, p< 0.001). We demonstrated in Multivariate
Linear regression model of predictive factors that age and concomitant COPD comorbidities were
the main predictive factors for wrinkling in patients with COPD with t= 6.968, at p< 0.001 and
t= 3.473, at p< 0.002, respectively.
844 M.H. Zidan et al.Conclusion: Facial wrinkling is strongly associated with the risk of airﬂow obstruction. Extensive
facial wrinkling may be a marker of susceptibility to the effects of cigarette smoking and should
promote the screening of affected individuals for airﬂow obstruction.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.Introduction
Cigarette smoking is associated with facial wrinkling [1–7] that
increases with the number of pack years of smoking [2,5].
Smoking is also the major risk factor for the development of
chronic obstructive pulmonary disease (COPD).
COPD is a heterogeneous syndrome of chronic bronchitis,
small airways disease, and alveolar destruction (emphysema)
that varies in proportion between affected individuals. It is well
recognized that only a proportion of cigarette smokers develop
COPD [8,9], and that this is likely to be the result of genetic
susceptibility to the effects of cigarette smoking [10,11].
Both smoking related facial wrinkling and emphysema may
be likened to premature ageing of the tissues. Thus it is plau-
sible that the genetic factors that predispose smokers to COPD
also predispose smokers to wrinkling of the skin.
The objective of our study was to test the hypothesis that
facial wrinkling is a reﬂection to the severity of COPD disease.
Speciﬁcally, we examined whether there was an association
between facial wrinkling and the severity of COPD as assessed
by different parameters retrieved from GOLD criteria as well
as clinical based parameters.Table 1 Illustrating demographic data of the studied patients.
Gender
Male 82 (82.0%)
Female 18 (18.0%)
Age 56.23 ± 10.74
Smoking history (pack/year) 70.19 ± 32.16
Smoking severity
Moderate 22 (22.0%)
Severe 78 (78.0%)
Post bronchodilator FEV1 65.13 ± 16.69Subjects and methods
The study included 100 patients diagnosed with COPD
recruited from the Department of Chest Diseases as well as
Chest Department Outpatient Clinic, Faculty of Medicine,
Alexandria University, Egypt.
Demographic data and smoking exposure [12] were
obtained from all patients.
All patients were screened with spirometry for COPD
(deﬁned as a post-bronchodilator FEV1 <80% predicted
and FEV1/VC ratio <0.7). Spirometric measures [13] were
obtained pre- and post-bronchodilator. All measurements
were taken by trained operators using a standardized protocol.
Based on the patient’s level of symptoms using Modiﬁed
British Medical Research Council (mMRC) Questionnaire,
exacerbation history, the severity of the spirometric abnormal-
ity, and the identiﬁcation of comorbidities, each patient was
given a score of combined assessment of COPD [14,15].
Photographs of the left and right temporal region of the
face were taken. Photographs were taken under standardized
lighting conditions with a marker placed on the skin to allow
accurate determination of scale. The extent of facial wrinkling
was determined from photographs of the left and right tempo-
ral region of the face and the extent of facial wrinkling in the
‘‘crows’ feet area’’ was determined using the scoring system
described by Daniell [1]. This scores wrinkling from I to VI
(grade I, essentially unwrinkled; grade II, several wrinkles
(up to 6) up to 3 cm in length; grade III, several prominent
wrinkles on each side 3–4 cm long; grade IV, wrinkles extendsuperiorly and inferiorly and are 5 cm long; grade V, wrinkles
extend from the crows’ feet area and are prominent over
cheeks and forehead; and grade VI, profound wrinkling
extending over most of the face).
The dermatologist was blind to the individuals’ smoking
history and spirometry results.
An additional questionnaire was completed by the partici-
pants to obtain information on sunlight exposure. The
questionnaire asked the individual to record if they had ever
worked outdoors, lived abroad in a hot sunny climate, took
regular holidays abroad in sunny climates (and if so, how
many), and if they regularly used sunscreen [4].
All subjects were enrolled in the study after a written
informed consent according to the protocol approved by the
Ethics Committee of the Hospital.
Results
Demographic data of the studied population
Among 100 studied patients with COPD, 82 were males
whereas 18 were females. Mean ± SD age of the studied
patients was 56.23 ± 10.74 years. Based on pack year index,
severity of smoking was classiﬁed as: 22 patients with
moderate grade of severity and 78 patients with a severe grade.
Mean ± SD value of pack year index for all the patients was
70.19 ± 32.16 packs/year. As regards post bronchodilator
FEV1% of predicted, mean ± SD value was 65.13 ±
16.69% of predicted (Table 1).
Descriptive data illustrating severity of COPD disease in the
studied patients depending on the different parameters assessed
Based on spirometry data (post bronchodilator FEV1% of
predicted)
20, 60, 17 and 3 patients were classiﬁed as mild (GOLD 1),
moderate (GOLD 2), severe (GOLD 3), and very severe
(GOLD 4), respectively. And accordingly, 80 patients showed
low risk (GOLD 1 + 2) while 20 patients showed high risk
(GOLD 3 + 4) according to combined assessment of COPD
(Table 2) (Fig. 1).
Table 2 Descriptive illustration of severity of COPD disease
in the studied patients depending on the different parameters
assessed.
Classiﬁcation of severity based on
post bronchodilator FEV1
65.13 ± 16.69
*Low risk (GOLD 1 + 2) 80 (80.0%)
Mild (GOLD 1) 20 (20.0%)
Moderate (GOLD 2) 60 (60.0%)
*High risk (GOLD 3 + 4) 20 (20.0%)
Severe (GOLD 3) 17 (17.0%)
Very severe (GOLD 4) 3 (3.0%)
Risk of exacerbations 1.0 (0.0–3.0)
*Low risk (0 + 1) 77 (77.0%)
*High risk (P2) 23 (23.0%)
mMRC Breathlessness scale 2.0 (1.0–5.0)
*Low symptoms (0 + 1) 23 (23.0%)
*More symptoms (P2) 77 (77.0%)
Combined COPD assessment system
*Low risks 66 (66.0%)
A 21 (21.0%)
B 45 (45.0%)
*High risks 34 (34.0%)
C 2 (2.0%)
D 32 (32.0%)
Data were presented as Median (Min.–Max.) for abnormally dis-
tributed data or Mean ± SD for normally distributed data. mMRC
Breathlessness scale: Modiﬁed British Medical Research Council
(mMRC) Questionnaire.
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Figure 1 Demonstrating classiﬁcation of risk and symptom
severity in the studied population based on the different param-
eters studied.
Table 3 Distribution of comorbidities among the studied
COPD patients.
COPD comorbidities
Negative 53 (53.0%)
Positive 47 (47.0%)
COPD Frequencies (n= 47)
Bronchiectasis 1 (1.4%)
Depression 15 (20.5%)
DM 27 (37.0%)
HTN 21 (28.8%)
IHD 8 (11.0%)
Liver cirrhosis 1 (1.4%)
Negative
53
53.0%
Positive
47
47.0%
Figure 2 Pie chart illustrating prevalence of COPD comorbid-
ities among the studied population.
Association between facial wrinkling and the severity of COPD 845Based on risk of exacerbations
77 patients reported less than 2 exacerbations/year that is low
risk whereas 23 patients reported 2 or more exacerbations/year
that high risk according to combined assessment of COPD
(Table 2) (Fig. 1).
Based on modiﬁed medical research council breathlessness scale
Twenty-three (23) patients demonstrated a scale of less than 2
that is low symptoms whereas the remaining 77 patientsshowed a scale of 2 or more that is more symptoms (Table 2)
(Fig. 1).
Based on combined COPD assessment system
Sixty-six (66) patients showed low risk and they were catego-
rized as follows: group A consisting of 21 patients (low risks,
low symptoms), and group B consisting of 45 patients (low
risks, more symptoms).
On the other hand, thirty-four (34) patients showed high
risk and they were categorized as follows: group C consisting
of 2 patients (high risks, low symptoms), and group D consist-
ing of 32 patients (high risks, more symptoms) (Table 2)
(Fig. 1).
Comorbidities in the studied patients
Regarding prevalence of concomitant systemic comorbidities
in patients with COPD, we found 53 patients free of comorbid-
ities while 47 suffered from concomitant comorbidities
(Table 3) (Fig. 2).
Concerning frequencies of these comorbidities, they were
categorized as follows: DM (n= 27 that is 37% of the studied
population), systemic hypertension (n= 21 that is 28.8% of
the studied population), depression (n= 15 that is 20.5% of
the studied population), IHD (n= 8 that is 11% of the studied
population), and lastly bronchiectasis (n= 1 that is 1.4% of
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Figure 4 Grades of wrinkling based on Daniell score in patients
with COPD.
846 M.H. Zidan et al.the studied population) and liver cirrhosis (n= 1 that is 1.4%
of the studied population) (Table 3) (Fig. 3).
Grades of wrinkling in patients with COPD according to Daniell
score
Based on Daniell scoring system, twenty-ﬁve (25) patients
showed grade 6 wrinkling, while 20 patients demonstrated
grade 5 wrinkling. Grade 4 wrinkling was present in 23
patients while grades 3, 2, and 1 were present in 14, 10, and
8 patients respectively (Table 4) (Fig. 4).
Comparative estimations of high risk patients in studied COPD
patients
Number of high risk COPD patients when calculated using
combined COPD assessment system (n= 34) was statistically
signiﬁcantly higher when compared to number of high risk
COPD patients derived from GOLD severity separately
(n= 20) with p< 0.001, or when compared to high risk group
derived from exacerbations history alone (n= 23), with
p< 0.001.
Our data showed that exacerbation history as a tool to
assess high risk COPD patients is more sensitive when com-
pared to post bronchodilator FEV1% of predicted as a sole
parameter with sensitivity of 64.7%, and 58.8% respectively
(Table 5) (Figs. 5 and 6).0
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Figure 3 Bar chart demonstrating distribution of different
comorbidities among patients with COPD according to their
frequencies.
Table 4 Description of grades of wrinkling based on Daniell
score in patients with COPD.
Grades of wrinkling with Daniell score 4.0 (1.0–6.0)
1 8 (8.0%)
2 10 (10.0%)
3 14 (14.0%)
4 23 (23.0%)
5 20 (20.0%)
6 25 (25.0%)Relation between COPD comorbidities with different studied
parameters
– The prevalence of systemic comorbidities in patients with
COPD was statistically signiﬁcantly higher in patients with
high risk of exacerbations compared to those of low risks,
with p= 0.013.
– Also patients with more symptoms based on mMRC scale
suffered from signiﬁcantly more concomitant comorbidities
compared to those with low symptoms, with p< 0.001.
– Statistically signiﬁcantly more diseases existed in COPD
patients with high risk based on combined assessment sys-
tem compared to those with low risk with p= 0.034.
– Age was also statistically signiﬁcantly higher in patients
with concomitant comorbidities compared to those without
with p= 0.038 (Table 6).
Relation between wrinkling score with gender, combined COPD
and COPD comorbidities
Regarding wrinkling score, a statistically signiﬁcantly higher
score was found in COPD patients with high risk based on
combined assessment system compared to those with low risk
with p< 0.001 (Table 7) (Fig. 6).
A statistically signiﬁcantly higher score of wrinkling was
found in COPD patients with more symptoms based on
mMRC breathlessness scale compared to those with low
symptoms with p< 0.001 (Table 7) (Fig. 7).
Wrinkling was also statistically signiﬁcantly higher in
COPD patients with concomitant comorbidities compared to
those without comorbidities with p< 0.001 (Table 7)
(Fig. 8) (Table 8).
Correlations
Statistically signiﬁcant correlations existed between wrinkling
score and different parameters in COPD patients as follows
– There was a positive correlation between wrinkling score
and age of the patients (r= 0.738, p< 0.001) (Fig. 9).
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Figure 5 Comparison between combined COPD assessment
system versus FEV1 and risk of exacerbations to calculate high
risk patients.
Figure 6 Relation between wrinkling score and risk estimation
based on combined COPD assessment system.
Table 5 Comparison between combined COPD assessment system versus FEV1 and risk of exacerbations to calculate high risk
patients.
Combined COPD assessment p Sensitivity Speciﬁcity PPV NPV Accuracy (agreement)
Low risks (n= 66) High risks (n= 34)
Classiﬁcation of severity FEV1
Low risk (GOLD 1 + 2) 66 (66.0%) 14 (14.0%) <0.001 58.8 100.0 100.0 82.5 86.0
High risk (GOLD 3 + 4) 0 (0%) 20 (20.0%)
Risk of exacerbations
Low risk (0 + 1) 65 (65.0%) 12 (12.0%) <0.001* 64.7 98.4 95.6 84.4 87.0
High risk (P2) 1 (1.0%) 22 (22.0%)
* p< 0.001.
Association between facial wrinkling and the severity of COPD 847– There was a positive correlation between wrinkling score
and smoking severity of the patients (r= 0.326,
p< 0.001) (Fig. 10).
– There was a negative correlation between wrinkling score
and post bronchodilator FEV1% of predicted values
(r= 0.673, p< 0.001) (Fig. 11).– There was a positive correlation between wrinkling score
and severity of COPD based on post bronchodilator
FEV1 (r= 0.547, p< 0.001) (Fig. 12).
– There was a positive correlation between wrinkling score
and risk of exacerbations (r= 0.333, p< 0.001).
– There was a positive correlation between wrinkling score
and modiﬁed medical research council breathlessness scale
(r= 0.602, p< 0.001) (Fig. 13).
– Combined COPD assessment signiﬁcantly positively corre-
lated with wrinkling score (r= 0.573, p< 0.001) (Fig. 14).
Multivariate Linear regression model of predictive factors
showed age and concomitant COPD comorbidities as the main
predictive factors for wrinkling in patients with COPD with
t= 6.968, at p< 0.001 and t= 3.473, at p< 0.002, respectively.
Discussion
The results of our study demonstrated that wrinkling score was
statistically signiﬁcantly higher in COPD patients with high
risk based on combined assessment system compared to those
with low risk with p< 0.001. Also, a statistically signiﬁcantly
higher score of wrinkling was found in COPD patients with
more symptoms based on mMRC breathlessness scale com-
pared to those with low symptoms with p< 0.001. We also
found that wrinkling was statistically signiﬁcantly higher in
COPD patients with concomitant comorbidities compared to
those without comorbidities with p< 0.00.
Positive correlations existed between wrinkling score and:
age of the patients (r= 0.738, p< 0.001), smoking severity
of the patients (r= 0.326, p< 0.001), and severity of COPD
based on post bronchodilator FEV1 (r= 0.547, p< 0.001).
There were also positive correlations between wrinkling
score and: risk of exacerbations (r= 0.333, p< 0.001), modi-
ﬁed medical research council breathlessness scale (r= 0.602,
p< 0.001) and combined COPD assessment (r= 0.573,
p< 0.001). There was a negative correlation between wrin-
kling score and post bronchodilator FEV1% of predicted val-
ues (r= 0.673, p< 0.001).
We demonstrated in Multivariate Linear regression model
of predictive factors that age and concomitant COPD comor-
bidities were the main predictive factors for wrinkling in
patients with COPD with t= 6.968, at p< 0.001 and
t= 3.473, at p< 0.002, respectively.
In concordance to our ﬁndings, Patel et al. [16] demon-
strated that severe facial wrinkling (Daniell score >IV) was
Table 7 Relation between wrinkling score with gender,
combined COPD and COPD comorbidities.
Wrinkling score p
Gender
Male 4.0 (1.0–6.0) 0.953
Female 4.50 (1.0–6.0)
Combined COPD
Low risks 4.0 (1.0–6.0) <0.001*
High risks 5.0 (2.0–6.0)
Severity of symptoms of COPD
Less symptoms 2.0 (1.0–6.0) <0.001*
More symptoms 5.0 (1.0–6.0)
COPD comorbidities
Negative 4.0 (1.0–6.0) <0.001*
Positive 5.0 (2.0–6.0)
Values were expressed as median (Min.–Max.).
* p< 0.001. Figure 7 Relation between wrinkling score and severity of
symptoms of COPD.
Table 6 Relation between COPD comorbidities with different studied parameters.
COPD comorbidities p
Negative (n= 53) Positive (n= 47)
Classiﬁcation of severity FEV1
GOLD 1 13 (13.0%) 7 (7%) 0.366
GOLD 2 30 (30.0%) 30 (30.0%)
GOLD 3 8 (8.0%) 9 (9.0%)
GOLD 4 2 (2.0%) 1 (1.0%)
Classiﬁcation of severity FEV1 GOLD risk
Low risk (GOLD 1–2) 43 (43.0%) 37 (37.0%) 0.764
High risk (GOLD 3–4) 10 (10.0%) 10 (10.0%)
Risk of exacerbations
Low risk GOLD (1–2) 46 (46.0%) 31 (31.0%) 0.013*
High risk GOLD (3–4) 7 (7.0%) 16 (16.0%)
Combined COPD assessment
Less symptoms 21 (21.0%) 2 (2.0 %) <0.001*
More symptoms 32 (32.0%) 45 (45.0%)
Combined COPD assessment
A 20 (20.0%) 1 (1.0%) <0.001*
B 20(20.0%) 25 (25.0%)
C 1 (1.0%) 1 (1.0%)
D 12 (12.0%) 20 (20.0%)
Combined COPD assessment
Low risks 40 (40.0%) 26 (26.0%) 0.034*
High risks 13 (13.0%) 21 (21.0%)
Smoking severity
Moderate 15 (15.0%) 7 (7.0%) 0.106
Severe 38 (38.0%) 40 (40.0%)
Age 54.17 ± 11.80 58.55 ± 8.97 0.038*
Smoking history 65.15 ± 32.84 75.87 ± 30.72 0.096
Risk of exacerbations 0.0 (0.0–3.0) 1.0 (0.0–3.0) 0.060
mMRC breathlessness scale 2.0 (1.0–5.0) 3.0 (1.0–5.0) 0.036*
Grade of wrinkling score 4.0 (1.0–6.0) 5.0 (2.0–6.0) <0.001*
Post bronchodilator 66.51 ± 17.42 63.57 ± 15.87 0.383
Data were presented as Median (Min.–Max.) for abnormally distributed data or Mean ± SD for normally distributed data.
* p< 0.001.
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Figure 8 Relation between wrinkling score and COPD
comorbidities.
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Figure 9 Correlation between wrinkling score and age of the
patients (years).
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Figure 10 Correlation between wrinkling score and smoking
severity.
Association between facial wrinkling and the severity of COPD 849signiﬁcantly associated with a lower mean FEV1 and COPD.
However in contradiction to our results, they found that these
associations were independent of the effects of age and cumu-
lative pack years smoked.
In an earlier study, Kadunce and colleagues [2] found
smoking to be associated with an increased risk of severe facial
wrinkling. However, they observed that only 27% of smokers
with more than 50 pack year’s exposure were affected. They
postulated that, as with COPD, there may be a subgroup of
smokers who are susceptible to facial wrinkling.
Our ﬁndings supported this hypothesis and suggested that
there may be a common susceptibility to the two conditions.
In our study, people with more severe facial wrinkling and
COPD were signiﬁcantly older and had smoked signiﬁcantly
more pack years than those without.
We also tried to adjust for sun exposure as this has been
associated with facial wrinkling [4]. However, to be a signiﬁ-
cant confounder of the association between wrinkling and air-
ﬂow obstruction, sun exposure would also have to be
associated with the risk of COPD. Since we have no reason
to suppose that sun exposure is associated with the risk of
COPD, it is not surprising that sun exposure was not signiﬁ-
cant as a covariate in the regression analyses.
The ﬁndings of this study inevitably raise the question ‘‘Is it
possible to predict the presence of COPD in smokers from
their facial appearance?’’. The predictive value of severe wrin-Table 8 Multivariate analysis linear regression for wrinkling score.
B
Age 0.077
Smoking history 0.001
Smoking severity 0.079
Post bronchodilator FEV1 0.005
Classiﬁcation of severity FEV1 0.678
Risk of exacerbations 0.207
mMRC breathlessness scale 0.198
Combined COPD assessment 0.157
COPD comorbidities 0.709
R2 = 0.688, SE = 0.921, F= 22.017*, p 6 0.001*.kling for airﬂow obstruction in smokers is dependent upon the
sensitivity and speciﬁcity of wrinkling for predicting COPD
and the prevalence of COPD in the population assessed.
In a cross sectional study of over 13,000 individuals done
by Lange P and Schnohr [17], severe facial wrinkling was
found to be associated with a mean reduction in FEV1/FVCSE t p
0.011 6.968* <0.001*
0.005 0.115 0.909
0.296 0.267 0.790
0.015 0.329 0.743
0.294 2.306 0.023
0.126 1.646 0.103
0.131 1.514 0.133
0.169 0.928 0.356
0.204 3.473* 0.002*
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Figure 11 Correlation between wrinkling score and post bron-
chodilator FEV1% of predicted values.
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breathlessness scale.
0
1
2
3
4
5
6
1 2 3 4 5 6
W
ri
nk
lin
g 
sc
or
e 
Combined COPD assessment
rs = 0.573*
p < 0.001
Figure 14 Correlation between wrinkling score and combined
COPD assessment system.
850 M.H. Zidan et al.of 1.2–1.9% predicted in current and ex-smokers (but not in
non-smokers) which is a ﬁnding consistent with our current
study, however the magnitude of the association is far smaller
than that found by Patel et al. [16]. It is unclear what propor-
tion of smokers in that study had COPD, so the relatively
modest association may be a consequence of an over-represen-
tation of healthy individuals or subjects (that is, non-suscepti-
ble smokers) in the study population. In contrast, Patel et al.
have studied a group of individuals with a high prevalence of
COPD. They recruited families identiﬁed through a proband
with relatively early onset COPD. They have previously shown
that the siblings of probands who smoke have a greater risk of
developing airﬂow obstruction than unrelated controls, and
this suggested that there may be a genetic predisposition to
the development of COPD [11,10].
Our results suggest that the presence of facial wrinkling in
this susceptible group is strongly predictive of the presence
of airﬂow obstruction. Severe facial wrinkling may therefore
be a marker of COPD susceptibility and should alert the clini-
cian to assess such individuals for the presence of COPD.
Moreover, the association between facial wrinkling and COPDsuggests that there may be a common mechanism and perhaps
a common genetic susceptibility. It seems likely that changes in
the collagen and elastin are important in the pathogenesis of
both lung and skin pathologies. Wrinkling may be the conse-
quence of metalloproteinases that are activated as a conse-
quence of smoking [18] or a defect in repair mechanisms that
affects both the skin and the lungs.
In summary, we have found that facial wrinkling is strongly
associated with the risk of airﬂow obstruction. Extensive facial
wrinkling may be a marker of susceptibility to the effects of
cigarette smoking and should promote the screening of
affected individuals for airﬂow obstruction.
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